CVS
40
3
KMX
38
-9
LUV
70
2
HP
41
3
DRI
63
-3
INTC
40
-3
IP
34
6
PNR
54
3
ROST
68
-3
DUK
55
3
PRU
60
-2
LMT
62
3
V
54
2
OI
58
11
SE
54
5
NWSA
79
15
GWW
67
2
BLK
63
5
CNP
52
3
ACN
54
-2
CVS
40
3
KMX
38
-9
LUV
70
2
HP
41
3
DRI
63
-3
INTC
40
-3
IP
34
6
PNR
54
3
ROST
68
-3
DUK
55
3
PRU
60
-2
LMT
62
3
V
54
2
OI
58
11
SE
54
5
NWSA
79
15
GWW
67
2
BLK
63
5
CNP
52
3
ACN
54
-2
Financhill
Back

Probe Gold, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Buy
63

PROBF
Probe Gold, Inc.

Last Price:
$2.64
Seasonality Move:
24.14%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$43.48
Seasonality Move:
6.44%
Buy
63
Probe Gold, Inc. (PROBF) is a Buy

Is Probe Gold, Inc. a Buy, Sell or Hold?

  • The current Probe Gold, Inc. [PROBF] share price is $2.64. The Score for PROBF is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • PROBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $43.48. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PROBF Stock Price Chart

What is Probe Gold, Inc.'s stock price today?

  • The Probe Gold, Inc. share price today is $2.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PROBF is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $43.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

PROBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 60.92 Buy
Chaikin Money Flow: -90531 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.59 - 2.65) Buy
Bollinger Bands (100): (1.81 - 2.55) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.36 Sell
Relative Strength Index (14 RSI): 35.32 Sell
Chaikin Money Flow: -1120535 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.64 - 61.4) Sell
Bollinger Bands (100): (35.47 - 62.69) Sell

PROBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.65 Sell
20-day SMA: 2.63 Buy
50-day SMA: 2.45 Buy
200-day SMA: 1.87 Buy
8-day EMA: 1.67 Buy
20-day EMA: 0.87 Buy
50-day EMA: 0.39 Buy
200-day EMA: 0.1 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.5 Sell
20-day SMA: 54.97 Sell
50-day SMA: 57.15 Sell
200-day SMA: 31.68 Buy
8-day EMA: 48.23 Sell
20-day EMA: 52.53 Sell
50-day EMA: 53.87 Sell
200-day EMA: 38.39 Buy

Probe Gold, Inc. Earnings Growth & PROBF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.

Probe Gold, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):